As this involves human death, the process will be extremely tedious.
They'll have to discuss internally to study the cause of death. From there deliberate on what changes has to be made to their internal protocol. Have to convene with internal human ethics commission before presenting to the FDA. After which the FDA will deliberate on it, and propose a recommendation or changes to be made based of the deliberation.
There isn't a set timeline and the management will not be able to confirm these information publicly yet, but my understanding with my close mate who is in this field has hinted that these things could take a longer time than what we have gone through before any confirmations are made.
It quite depends also on whether it was the drugs administered had any direct effect on the death. You could deduce that if they have found out that it is confirmed not to be the drugs, the process could be shortened.
PTX Price at posting:
6.2¢ Sentiment: Hold Disclosure: Held
